![James Cornwall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Cornwall is currently the Head of Business Development at Abingworth Management, Inc. Prior to this, he worked as a Director at SAMSUNG BIOLOGICS Co., Ltd. in 2011 and as a Vice President-Corporate Development at Quintiles Transnational Corp.
| Unternehmen | Position | Beginn |
|---|---|---|
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01.04.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development, marketing & public opinion polling services | Corporate Officer/Principal | - |
| SAMSUNG BIOLOGICS CO.,LTD. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development, marketing & public opinion polling services | Commercial Services |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Finance |
SAMSUNG BIOLOGICS Co., Ltd.
 SAMSUNG BIOLOGICS Co., Ltd. BiotechnologyHealth Technology Provides biologics development and manufacturing solutions | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
